Dong-Jo Kim

Title: Innovations of Dong-Jo Kim in Monoclonal Antibodies

Introduction

Dong-Jo Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on enhancing the identification and isolation of human mesenchymal stem cells, which are crucial for various medical applications.

Latest Patents

Dong-Jo Kim holds a patent for "Monoclonal antibodies to mesenchymal stem cells." This invention relates to monoclonal antibodies that specifically bind to a membrane antigen of human mesenchymal stem cells. The patent describes hybridoma cell lines that produce these antibodies and methods for identifying or isolating human mesenchymal stem cells using them. The monoclonal antibodies exhibit excellent specificity to human mesenchymal stem cells, particularly those derived from bone marrow, allowing for more precise identification and isolation.

Career Highlights

Dong-Jo Kim is affiliated with Seoul National University, where he conducts research and develops innovative solutions in biotechnology. His work has garnered attention for its potential applications in regenerative medicine and cell therapy.

Collaborations

Some of his notable coworkers include Yeong-Wook Song and Hyun-Jung Yoo, who have collaborated with him on various research projects.

Conclusion

Dong-Jo Kim's contributions to the field of monoclonal antibodies represent a significant advancement in biotechnology. His innovative work continues to pave the way for improved methods in stem cell research and applications.